Kawai R - Search Results

1

Modeling the kinetics of release of octreotide from long-acting formulations injected intramuscularly in rabbits.

Comets E, Mentré F, Kawai R, Nimmerfall F, Marbach P, Vonderscher J. Comets E, et al. Among authors: kawai r. J Pharm Sci. 2000 Sep;89(9):1123-33. doi: 10.1002/1520-6017(200009)89:9<1123::aid-jps4>3.0.co;2-k. J Pharm Sci. 2000. PMID: 10944377

2

Nonparametric analysis of the absorption profile of octreotide in rabbits from long-acting release formulation OncoLAR.

Comets E, Mentré F, Nimmerfall F, Kawai R, Mueller I, Marbach P, Vonderscher J. Comets E, et al. Among authors: kawai r. J Control Release. 1999 May 20;59(2):197-205. doi: 10.1016/s0168-3659(98)00194-1. J Control Release. 1999. PMID: 10332054

3

Population pharmacodynamic analysis of octreotide in acromegalic patients.

Comets E, Mentré F, Grass P, Kawai R, Marbach P, Vonderscher J. Comets E, et al. Among authors: kawai r. Clin Pharmacol Ther. 2003 Jan;73(1):95-106. doi: 10.1067/mcp.2003.6. Clin Pharmacol Ther. 2003. PMID: 12545148

4

Ethnic sensitivity study of fingolimod in white and Asian subjects.

Kovarik JM, Slade A, Voss B, Schmidli H, Riviere GJ, Picard F, Sugita Y, Kawai R, Mee-Lee D, Schmouder RL. Kovarik JM, et al. Among authors: kawai r. Int J Clin Pharmacol Ther. 2007 Feb;45(2):98-109. doi: 10.5414/cpp45098. Int J Clin Pharmacol Ther. 2007. PMID: 17323789 Clinical Trial.

5

Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents.

O'Reilly T, McSheehy PM, Kawai R, Kretz O, McMahon L, Brueggen J, Bruelisauer A, Gschwind HP, Allegrini PR, Lane HA. O'Reilly T, et al. Among authors: kawai r. Cancer Chemother Pharmacol. 2010 Mar;65(4):625-39. doi: 10.1007/s00280-009-1068-8. Epub 2009 Sep 27. Cancer Chemother Pharmacol. 2010. PMID: 19784839

6

Dose-dependent pharmacokinetics of cyclosporin A in rats: events in tissues.

Tanaka C, Kawai R, Rowland M. Tanaka C, et al. Among authors: kawai r. Drug Metab Dispos. 2000 May;28(5):582-9. Drug Metab Dispos. 2000. PMID: 10772639

7

Physiologically based pharmacokinetic (PBPK) modeling of everolimus (RAD001) in rats involving non-linear tissue uptake.

Laplanche R, Meno-Tetang GM, Kawai R. Laplanche R, et al. Among authors: kawai r. J Pharmacokinet Pharmacodyn. 2007 Jun;34(3):373-400. doi: 10.1007/s10928-007-9051-7. Epub 2007 Mar 13. J Pharmacokinet Pharmacodyn. 2007. PMID: 17431753

8

Physiologically based pharmacokinetics of cyclosporine A: extension to tissue distribution kinetics in rats and scale-up to human.

Kawai R, Mathew D, Tanaka C, Rowland M. Kawai R, et al. J Pharmacol Exp Ther. 1998 Nov;287(2):457-68. J Pharmacol Exp Ther. 1998. PMID: 9808668

9

Effect of PSC 833, a P-glycoprotein modulator, on the disposition of vincristine and digoxin in rats.

Song S, Suzuki H, Kawai R, Sugiyama Y. Song S, et al. Among authors: kawai r. Drug Metab Dispos. 1999 Jun;27(6):689-94. Drug Metab Dispos. 1999. PMID: 10348798

10

Perspectives in pharmacokinetics. Physiologically based pharmacokinetic modeling as a tool for drug development.

Charnick SB, Kawai R, Nedelman JR, Lemaire M, Niederberger W, Sato H. Charnick SB, et al. Among authors: kawai r. J Pharmacokinet Biopharm. 1995 Apr;23(2):217-29. doi: 10.1007/BF02354273. J Pharmacokinet Biopharm. 1995. PMID: 8719238 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters